Although previous studies have reported the correlation between CD200 expression level in MM cells and survival (26–28), there are not data concerning the potential impact of genetic polymorphisms in the CD200 gene on clinical outcome in patients with MM. Here, CD200 is linked to Miyoshi myopathy.